Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience
Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience
Background: culture-independent analysis of the respiratory secretions of people with cystic fibrosis (CF) has identified many bacterial species not previously detected using culture in this context. However, little is known about their clinical significance or persistence in CF airways.
Methods: the authors characterised the viable bacterial communities in the sputum collected from 14 patients at monthly intervals over 1 year using a molecular community profiling technique-terminal restriction fragment length polymorphism. Clinical characteristics were also collected, including lung function and medications. Ecological community measures were determined for each sample. Microbial community change over time within subjects was defined using ecological analytical tools, and these measures were compared between subjects and to clinical features.
Results: bacterial communities were stable within subjects over time but varied between subjects, despite similarities in clinical course. Antibiotic therapy temporarily perturbed these communities which generally returned to pretreatment configurations within 1 month. Species usually considered CF pathogens and those not previously regarded as such exhibited similar patterns of persistence. Less diverse sputum bacterial communities were correlated to lung disease severity and relative abundance of Pseudomonas aeruginosa.
Conclusions: whilst not true in all cases, the microbial communities that chronically infect the airways of patients with CF can vary little over a year despite antibiotic perturbation. The species present tended to vary more between than within subjects, suggesting that each CF airway infection is unique, with relatively stable and resilient bacterial communities. The inverse relationship between community richness and disease severity is similar to findings reported in other mucosal infections.
Adult, Anti-Bacterial Agents/pharmacology, Bacterial Load/drug effects, Biodiversity, Cystic Fibrosis/drug therapy, Disease Progression, Female, Humans, Male, Metagenome, Polymorphism, Restriction Fragment Length, Principal Component Analysis, Respiratory System/microbiology, Sputum/microbiology
867-73
Stressmann, Franziska Anne
1ece6bb7-0106-4f1a-ab4f-1159bfe7c9de
Rogers, Geraint B.
bd90d82a-4150-4e01-a755-b81559586da2
van der Gast, Christopher J.
eb316b36-8eff-4508-a17a-64fe024d5611
Marsh, Peter
18f63c35-264b-4ec9-8505-9c57bf707ad2
Vermeer, Louic S.
631f1335-8312-424c-a747-cc159cb47bd7
Carroll, Mary P.
b836d262-6b07-4006-9c81-26653a26588b
Hoffman, Lucas
96da3b2b-cc89-4c0b-8819-fc3920459778
Daniels, Thomas W.V.
9a8ab6f0-2eb9-4703-b536-f86923888213
Patel, Nilesh
80e4ce75-e037-4adf-a7a5-7c8e4253566d
Forbes, Benjamin
5a92eda9-33a1-4038-aaed-58ff19b936e4
Bruce, Kenneth Deans
82717699-c366-4360-956d-718b5bdd6d49
Stressmann, Franziska Anne
1ece6bb7-0106-4f1a-ab4f-1159bfe7c9de
Rogers, Geraint B.
bd90d82a-4150-4e01-a755-b81559586da2
van der Gast, Christopher J.
eb316b36-8eff-4508-a17a-64fe024d5611
Marsh, Peter
18f63c35-264b-4ec9-8505-9c57bf707ad2
Vermeer, Louic S.
631f1335-8312-424c-a747-cc159cb47bd7
Carroll, Mary P.
b836d262-6b07-4006-9c81-26653a26588b
Hoffman, Lucas
96da3b2b-cc89-4c0b-8819-fc3920459778
Daniels, Thomas W.V.
9a8ab6f0-2eb9-4703-b536-f86923888213
Patel, Nilesh
80e4ce75-e037-4adf-a7a5-7c8e4253566d
Forbes, Benjamin
5a92eda9-33a1-4038-aaed-58ff19b936e4
Bruce, Kenneth Deans
82717699-c366-4360-956d-718b5bdd6d49
Stressmann, Franziska Anne, Rogers, Geraint B., van der Gast, Christopher J., Marsh, Peter, Vermeer, Louic S., Carroll, Mary P., Hoffman, Lucas, Daniels, Thomas W.V., Patel, Nilesh, Forbes, Benjamin and Bruce, Kenneth Deans
(2012)
Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.
Thorax, 67 (10), .
(doi:10.1136/thoraxjnl-2011-200932).
Abstract
Background: culture-independent analysis of the respiratory secretions of people with cystic fibrosis (CF) has identified many bacterial species not previously detected using culture in this context. However, little is known about their clinical significance or persistence in CF airways.
Methods: the authors characterised the viable bacterial communities in the sputum collected from 14 patients at monthly intervals over 1 year using a molecular community profiling technique-terminal restriction fragment length polymorphism. Clinical characteristics were also collected, including lung function and medications. Ecological community measures were determined for each sample. Microbial community change over time within subjects was defined using ecological analytical tools, and these measures were compared between subjects and to clinical features.
Results: bacterial communities were stable within subjects over time but varied between subjects, despite similarities in clinical course. Antibiotic therapy temporarily perturbed these communities which generally returned to pretreatment configurations within 1 month. Species usually considered CF pathogens and those not previously regarded as such exhibited similar patterns of persistence. Less diverse sputum bacterial communities were correlated to lung disease severity and relative abundance of Pseudomonas aeruginosa.
Conclusions: whilst not true in all cases, the microbial communities that chronically infect the airways of patients with CF can vary little over a year despite antibiotic perturbation. The species present tended to vary more between than within subjects, suggesting that each CF airway infection is unique, with relatively stable and resilient bacterial communities. The inverse relationship between community richness and disease severity is similar to findings reported in other mucosal infections.
This record has no associated files available for download.
More information
Accepted/In Press date: 9 May 2012
e-pub ahead of print date: 15 June 2012
Keywords:
Adult, Anti-Bacterial Agents/pharmacology, Bacterial Load/drug effects, Biodiversity, Cystic Fibrosis/drug therapy, Disease Progression, Female, Humans, Male, Metagenome, Polymorphism, Restriction Fragment Length, Principal Component Analysis, Respiratory System/microbiology, Sputum/microbiology
Identifiers
Local EPrints ID: 487808
URI: http://eprints.soton.ac.uk/id/eprint/487808
ISSN: 0040-6376
PURE UUID: bc04a9c2-2b06-4315-8c3e-6641082b5089
Catalogue record
Date deposited: 05 Mar 2024 18:29
Last modified: 17 Mar 2024 07:51
Export record
Altmetrics
Contributors
Author:
Franziska Anne Stressmann
Author:
Geraint B. Rogers
Author:
Christopher J. van der Gast
Author:
Peter Marsh
Author:
Louic S. Vermeer
Author:
Mary P. Carroll
Author:
Lucas Hoffman
Author:
Thomas W.V. Daniels
Author:
Nilesh Patel
Author:
Benjamin Forbes
Author:
Kenneth Deans Bruce
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics